Dashboard
Manage Tickers

SLNSilence Therapeutics plc

Nasdaq silence-therapeutics.com


$ 18.03 $ -0.68 (-3.63 %)    

Tuesday, 02-Jul-2024 15:59:35 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 486.52 $ 5.06 (1.05 %)
DIA $ 393.25 $ 1.83 (0.47 %)
SPY $ 548.30 $ 3.67 (0.67 %)
TLT $ 90.61 $ 0.70 (0.78 %)
GLD $ 215.57 $ -0.01 (0 %)
$ 18.06
$ 18.49
$ 0.00 x 0
$ 0.00 x 0
$ 17.88 - $ 18.49
$ 4.84 - $ 27.72
299,212
na
2.15B
$ 1.06
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

morgan-stanley-maintains-overweight-on-silence-therapeutics-raises-price-target-to-49
Morgan Stanley Maintains Overweight on Sil...
06/28/2024 15:48:55

Morgan Stanley analyst Michael Ulz maintains Silence Therapeutics (NASDAQ:SLN) with a Overweight and raises the price target...

chardan-capital-maintains-buy-on-silence-therapeutics-raises-price-target-to-55
Chardan Capital Maintains Buy on Silence T...
06/28/2024 12:20:04

Chardan Capital analyst Keay Nakae maintains Silence Therapeutics (NASDAQ:SLN) with a Buy and raises the price target from $...

hc-wainwright--co-reiterates-buy-on-silence-therapeutics-maintains-75-price-target
HC Wainwright & Co. Reiterates Buy on Sile...
06/27/2024 16:07:20

HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 p...

silence-therapeutics-reports-results-from-ongoing-sanreco-phase-1-repeat-dose-study-of-divesiran-says-data-support-advancing-divesiran-into-phase-2
Silence Therapeutics Reports Results From ...
06/27/2024 11:32:44

Of the 16 patients, 8 patients are considered well-controlled and 8 patients have HCT levels over 45% at baseline.  To date, d...

silence-therapeutics-to-receive-2m-research-milestone-payment-from-hansoh-pharma-following-the-achievement-of-a-second-undisclosed-milestone-related-to-the-first-target-under-the-collaboration
Silence Therapeutics To Receive $2M Resear...
06/24/2024 12:35:16

Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), an experienced and innovative biotechnology...

the-analyst-landscape-6-takes-on-silence-therapeutics
The Analyst Landscape: 6 Takes On Silence ...
06/20/2024 16:00:38

hc-wainwright--co-reiterates-buy-on-silence-therapeutics-maintains-75-price-target
HC Wainwright & Co. Reiterates Buy on Sile...
06/20/2024 15:32:59

HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 p...

silence-therapeutics-announces-topline-48-week-data-phase-2-zerlasiran-study-showing-sustained-reductions-in-lpa-to-week-48
Silence Therapeutics Announces Topline 48-...
06/20/2024 11:37:56

hc-wainwright--co-reiterates-buy-on-silence-therapeutics-maintains-75-price-target
HC Wainwright & Co. Reiterates Buy on Sile...
05/31/2024 10:33:38

HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 p...

hc-wainwright--co-reiterates-buy-on-silence-therapeutics-maintains-75-price-target
HC Wainwright & Co. Reiterates Buy on Sile...
05/24/2024 16:46:46

HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 p...

hc-wainwright--co-reiterates-buy-on-silence-therapeutics-maintains-75-price-target
HC Wainwright & Co. Reiterates Buy on Sile...
05/17/2024 17:40:53

HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 p...

what-7-analyst-ratings-have-to-say-about-silence-therapeutics
What 7 Analyst Ratings Have To Say About S...
05/17/2024 13:01:00

chardan-capital-maintains-buy-on-silence-therapeutics-maintains-42-price-target
Chardan Capital Maintains Buy on Silence T...
05/17/2024 12:50:28

Chardan Capital analyst Keay Nakae maintains Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $42 price target.

silence-therapeutics-q1-collaboration-revenue-124m-up-1m-yoy-cash-position-1528m
Silence Therapeutics Q1 Collaboration Reve...
05/16/2024 12:42:39

beyond-the-numbers-7-analysts-discuss-silence-therapeutics-stock
Beyond The Numbers: 7 Analysts Discuss Sil...
04/22/2024 18:00:53

morgan-stanley-maintains-overweight-on-silence-therapeutics-maintains-45-price-target
Morgan Stanley Maintains Overweight on Sil...
04/22/2024 17:29:59

Morgan Stanley analyst Michael Ulz maintains Silence Therapeutics (NASDAQ:SLN) with a Overweight and maintains $45 price tar...

silence-therapeutics-announces-jama-publication-of-additional-apollo-phase-1-data-for-zerlasiran-in-subjects-with-elevated-lipoproteina
Silence Therapeutics Announces JAMA Public...
04/08/2024 15:49:21

Silence Therapeutics plc, Nasdaq: SLN ("Silence" or the "Company"), an experienced and innovative biotechnology...

hc-wainwright--co-reiterates-buy-on-silence-therapeutics-maintains-75-price-target
HC Wainwright & Co. Reiterates Buy on Sile...
03/15/2024 16:57:20

HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 p...

these-analysts-boost-their-forecasts-on-silence-therapeutics-after-full-year-2023-results
These Analysts Boost Their Forecasts On Si...
03/14/2024 18:01:29

Silence Therapeutics Plc (NASDAQ: SLN) reported a loss for 2023 on Wednesday.

morgan-stanley-maintains-overweight-on-silence-therapeutics-raises-price-target-to-45
Morgan Stanley Maintains Overweight on Sil...
03/14/2024 16:33:40

Morgan Stanley analyst Michael Ulz maintains Silence Therapeutics (NASDAQ:SLN) with a Overweight and raises the price target...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)